Newsletter article
Novavax is absent from Australia’s 2021 vaccination schedule. But it could be a useful booster later on
The Conversation
25/06/2021
Abstract
Novavax recently released excellent results from phase 3 clinical trials, finding its COVID-19 vaccine demonstrated 90.4% efficacy overall after two doses given three weeks apart...
Details
- Title
- Novavax is absent from Australia’s 2021 vaccination schedule. But it could be a useful booster later on
- Authors/Creators
- C. M. Berry - Murdoch University, School of Medical, Molecular and Forensic Sciences
- Publication Details
- The Conversation
- Publisher
- The Conversation Media Group Ltd
- Identifiers
- 991005548666107891
- Murdoch Affiliation
- School of Medical, Molecular and Forensic Sciences
- Resource Type
- Newsletter article
Metrics
76 Record Views